ClinVar Miner

Submissions for variant NM_000038.6(APC):c.7490C>T (p.Ser2497Leu)

gnomAD frequency: 0.00031  dbSNP: rs141010008
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 19
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV004562271 SCV000166057 benign Familial adenomatous polyposis 1 2025-02-03 criteria provided, single submitter clinical testing
Ambry Genetics RCV000131590 SCV000186602 benign Hereditary cancer-predisposing syndrome 2015-09-12 criteria provided, single submitter clinical testing This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity.
GeneDx RCV000587624 SCV000209549 likely benign not provided 2020-08-25 criteria provided, single submitter clinical testing This variant is associated with the following publications: (PMID: 24728327, 25801821, 23910461, 11818965, 28389531)
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000587624 SCV000694118 benign not provided 2016-03-25 criteria provided, single submitter clinical testing Variant Summary: The c.7490C>T variant involves the alteration of a conserved nucleotide and 3/4 in silico tools predict a neutral outcome. The variant was observed in the large and broad cohorts of the ExAC project at an allele frequency of 0.033%, predominantly observed in the European (Non-Finnish) subpopulation at a frequency of 0.055%. This frequency exceeds the maximal expected allele frequency for a pathogenic variant in APC (0.006%), suggesting this is a benign polymorphism found primarily in population(s) of European origin. The variant was reported in a family affected by multiple colorectal adenomas and carcinoma, however was absent in two affected members and was present in 3 unaffected members, showing lack of segregation of the variant with disease (Al-Tassan_2002). While one reputable clinical lab has classified the variant as likely benign, others have classified it as a VUS. Considering the relatively high frequency of this variant in the general population as well as the lack of segregation seen in an affected family, this variant has been classified as Benign.
Mendelics RCV004562271 SCV000838150 benign Familial adenomatous polyposis 1 2023-08-22 criteria provided, single submitter clinical testing
Color Diagnostics, LLC DBA Color Health RCV000131590 SCV000910611 benign Hereditary cancer-predisposing syndrome 2016-03-22 criteria provided, single submitter clinical testing
Quest Diagnostics Nichols Institute San Juan Capistrano RCV000587624 SCV001133368 likely benign not provided 2020-02-21 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000587624 SCV001154481 uncertain significance not provided 2022-01-01 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV001153055 SCV001314303 likely benign APC-Associated Polyposis Disorders 2019-02-19 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign.
Institute for Clinical Genetics, University Hospital TU Dresden, University Hospital TU Dresden RCV000587624 SCV002011084 likely benign not provided 2021-11-03 criteria provided, single submitter clinical testing
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories RCV000587624 SCV002049735 likely benign not provided 2021-04-06 criteria provided, single submitter clinical testing
Genetic Services Laboratory, University of Chicago RCV000120032 SCV002069711 likely benign not specified 2021-04-30 criteria provided, single submitter clinical testing
Sema4, Sema4 RCV000131590 SCV002528093 benign Hereditary cancer-predisposing syndrome 2020-06-10 criteria provided, single submitter curation
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital RCV000120032 SCV002550657 likely benign not specified 2025-03-04 criteria provided, single submitter clinical testing
Myriad Genetics, Inc. RCV004562271 SCV005083665 likely benign Familial adenomatous polyposis 1 2024-04-09 criteria provided, single submitter clinical testing This variant is considered likely benign. This variant is strongly associated with less severe personal and family histories of cancer, typical for individuals without pathogenic variants in this gene [PMID: 25085752].
ITMI RCV000120032 SCV000084163 not provided not specified 2013-09-19 no assertion provided reference population
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000587624 SCV001744322 likely benign not provided no assertion criteria provided clinical testing
Clinical Genetics, Academic Medical Center RCV000587624 SCV001920215 likely benign not provided no assertion criteria provided clinical testing
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000587624 SCV001952102 likely benign not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.